Astec LifeSciences financials at a glance

+ Portfolio

The revenue of Astec LifeSciences is reported as 6.28166 billion Rupees in the fiscal year 2024. The earnings were 13.04 Rupees per share in 2024, which was 71.56 lower than 2022. And about 0.898 billion Rupees are reported as free cash flow in the financials of Astec LifeSciences 2024. Dividends of 1.5 Rupees per share were paid to shareholders of Astec LifeSciences stock NSEI:ASTEC in fiscal 2024.

Rp6.28B

Revenue

Rp13.04

Earnings Per Share

35.26%

Gross Margin %

Rp0.00M

Free Cash Flow

Revenue

6,281.66

Earnings Per Share

13.04

Gross Margin %

35.26

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2022	2021	2014
Rev.	Revenue	N/A	Rp6.28B	Rp6.77B	Rp5.55B	Rp0.00M
GM %	Gross Margin %	31.70%	35.26%	42.09%	38.12%	28.61%
OM	Operating Margin	-3.41%	6.91%	17.78%	16.06%	11.08%
EPS	Earnings Per Share	Rp-13.14	Rp13.04	Rp45.85	Rp33.21	Rp5.02
Div.	Dividends	N/A	Rp1.50	Rp1.50	Rp1.50	Rp0.00
PR %	Payout Ratio %	0	11.50%	3.27%	4.52%	0
Sha.	Shares	N/AM	19.61M	19.6M	19.59M	18.53M
OCF	Operating Cash Flow	N/A	Rp898.00M	Rp236.04M	Rp-81.62M	Rp0.00M
FCF	Free Cash Flow	N/A	Rp-,274.59M	Rp-,803.74M	Rp-1,106.90M	Rp0.00M
FCFS	Free Cash Flow Per Share	Rp-80.61	Rp-21.73	Rp-41.03	Rp-56.54	Rp-2.44

Astec LifeSciences financials at a glance

Financials

Discover